Publicaciones en las que colabora con GUILLERMO VELASCO DÍEZ (19)

2016

  1. Anticancer mechanisms of cannabinoids

    Current Oncology, Vol. 23, pp. S23-S32

2015

  1. Endocannabinoids and cancer

    Handbook of Experimental Pharmacology (Springer New York LLC), pp. 449-472

  2. Loss of Tribbles pseudokinase-3 promotes Akt-driven tumorigenesis via FOXO inactivation

    Cell Death and Differentiation, Vol. 22, Núm. 1, pp. 131-144

  3. TRIB3 suppresses tumorigenesis by controlling mTORC2/AKT/FOXO signaling

    Molecular and Cellular Oncology, Vol. 2, Núm. 3

2012

  1. Towards the use of cannabinoids as antitumour agents

    Nature Reviews Cancer, Vol. 12, Núm. 6, pp. 436-444

2011

  1. The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK

    Oncogene, Vol. 30, Núm. 2, pp. 245-252

2010

  1. The putative cannabinoid receptor GPR55 participates in the control of cancer cell proliferation

    EJC SUPPLEMENTS

2008

  1. Targeting cannabinoid receptors in brain tumors

    Cannabinoids and the Brain (Springer US), pp. 361-374

2007

  1. Cannabinoids and gliomas

    Molecular Neurobiology, Vol. 36, Núm. 1, pp. 60-67

2006

  1. A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme

    British Journal of Cancer, Vol. 95, Núm. 2, pp. 197-203

2005

  1. Cannabinoids and ceramide: Two lipids acting hand-by-hand

    Life Sciences

2004

  1. Hypothesis: Cannabinoid therapy for the treatment of gliomas?

    Neuropharmacology, Vol. 47, Núm. 3, pp. 315-323

2002

  1. De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis

    Biochemical Journal, Vol. 363, Núm. 1, pp. 183-188

2001

  1. Inhibition of glioma growth in vivo by selective activation of the CB2 cannabinoid receptor

    Cancer Research, Vol. 61, Núm. 15, pp. 5784-5789

1998

  1. Role of carnitine palmitoyltransferase I in the control of ketogenesis in primary cultures of rat astrocytes

    Journal of Neurochemistry, Vol. 71, Núm. 4, pp. 1597-1606

1997

  1. Metabolic stimulation of mouse spleen lymphocytes by low doses of Δ9-tetrahydrocannabinol

    Life Sciences, Vol. 60, Núm. 19, pp. 1709-1717

  2. δ9-tetrahydrocannabinol stimulates glucose utilization in C6 glioma cells

    Brain Research, Vol. 767, Núm. 1, pp. 64-71

1996

  1. Are cytoskeletal components involved in the control of hepatic carnitine palmitoyltransferase I activity?

    Biochemical and Biophysical Research Communications, Vol. 224, Núm. 3, pp. 754-759

1995

  1. Effects of anandamide on hepatic fatty acid metabolism

    Biochemical Pharmacology, Vol. 50, Núm. 6, pp. 885-888